about
Human Anti-Oxidation Protein A1M--A Potential Kidney Protection Agent in Peptide Receptor Radionuclide TherapyMolar pregnancy after tubal ligation in a patient with neuroendocrine tumour: when a rare condition coincides with an unexpected diagnosisAtypical presentation of carcinoid tumor with unresolved right shoulder pain: a case report.Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 Pathway.Human neuroendocrine tumor cell lines as a three-dimensional model for the study of human neuroendocrine tumor therapy.Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivoAn Unusual Cause for Sister Mary Joseph's Nodule: A Case Report.A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.Diagnosis and prediction of neuroendocrine liver metastases: a protocol of six systematic reviews.Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 casesSomatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs.Treatment of Hepatic Epithelioid Hemangioendothelioma: Finding Uses for Thalidomide in a New Era of MedicineMetanephrine neuroendocrine tumor marker detection by SERS using Au nanoparticle/Au film sandwich architecture.Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide.Patient with synchronous low grade leiomyosarcoma of the thigh, primary pancreatic neuroendocrine tumor, and lung metastases: Why biopsy of metastases should be the standardIn1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parametersA case of pulmonary carcinoid tumour in a pregnant woman successfully treated with bronchoscopic (electrocautery) therapy.Neuroendocrine tumors of the lungA new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)Immunohistochemical expression and prognostic value of ER, PR and HER2/neu in pancreatic and small intestinal neuroendocrine tumors.⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET.Duodenal somatostatinoma: a case report and review of the literature.Secretagogin is a novel marker for neuroendocrine differentiation.Solitary hypervascular liver metastasis from neuroendocrine tumor mimicking hepatocellular cancer: All that glitters is not goldCutaneous Metastasis of Neuroendocrine Carcinoma with Unknown Primary Site: Case Report and Review of the Literature.Everolimus in the treatment of neuroendocrine tumors of the respiratory and gastroenteropancreatic systems.Clinical profile and treatment outcomes of advanced neuroendocrine tumours in rural and regional patients: a retrospective study from a regional cancer centre in North Queensland, Australia.Two patients with a neuroendocrine tumour of the small intestine and paraneoplastic myasthenia gravis.Using electron microscopy and multivariate cluster analysis to determine diagnosis and prognosis in cases of neuroendocrine lung carcinoma.Neuroendocrine tumors show altered expression of chondroitin sulfate, glypican 1, glypican 5, and syndecan 2 depending on their differentiation grade.Initial Clinical Experience with 68Ga-DOTA-NOC Prepared Using 68Ga from Nanoceria-polyacrylonitrile Composite Sorbent-based 68Ge/68Ga Generator and Freeze-dried DOTA-NOC Kits.Activation of somatostatin 2 receptors in the brain and the periphery induces opposite changes in circulating ghrelin levels: functional implications.Endocrine tumors of the ileum: factors correlated with survival.Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component.Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.Is ⁶⁸Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?The role of pre-operative imaging and double balloon enteroscopy in the surgical management of small bowel neuroendocrine tumors: Is it necessary?Neuroendocrine tumors: An epidemiological study of 250 cases at a tertiary hospital.Primary low-grade neuroendocrine carcinoma of the skin: An exceedingly rare entity.Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea.
P2860
Q26773377-8C9E7DBC-21AB-4BE9-BBC4-DA6E600A4C79Q33629116-1C9EF131-CD44-4E15-B8E5-04DEA72C58CBQ33653772-C7EF77E9-A57E-4926-B851-A1655FF126B5Q34146539-D70BEC15-9BF4-47F0-A859-D0F17930DC7BQ34396791-E0D97456-2E1B-4DA4-8CC9-969A9FD40D1BQ34734429-82172983-40A7-4CB3-84DB-1A2D9413A157Q34900027-78C07E4E-BE9A-406F-886E-0CB055FEA18AQ35064499-408E45FD-6B57-47A8-B54F-86329D3BF49CQ35074944-078C7DF4-F630-4B24-943E-F3D9E2B6BA1EQ35232437-2ED41174-CF6C-4D12-B13F-B6EB44D346F1Q35571226-1B88BEB4-2E79-45D8-9311-8C9CF557BCFFQ35807250-194F0CA1-2000-4155-A9A9-F5015E834814Q35907057-2C9C5855-E019-4D7B-959F-F338E5029C7FQ35999552-BB053103-56FF-48E8-9B4E-FAF1A1882F9CQ36097160-19784AC5-0BEB-4336-894B-6EC51C464DD1Q36260604-DBC11D11-3E52-4651-BEA0-BA21A51CF17CQ36818420-60E53CDE-8033-4672-8BD0-EEE70B439110Q37017067-792BFA97-D386-45CB-9F88-8C39CD53A7C8Q37295241-CA6BE320-70C3-49D3-9F73-7D879F614C96Q37864496-D4FA0835-FA19-41C7-8470-BD49D3C40A1CQ37990397-6F1E17F4-140B-4642-8536-5FF19B297D15Q38101692-4DC08E44-2ECD-42D5-8B3E-DF430A9AE4E7Q38316260-2479976D-BA04-4B48-9A33-9388CC9CE803Q38318787-3636FE19-7F74-48AF-9EBB-9B107D817621Q38630163-FCEB066E-8B70-47FA-A94D-1698C264B577Q38842250-434C4EB2-CA05-47AD-978B-EB480FA11717Q39176800-84153FB2-775D-4122-9583-DEE9C41A8DEEQ39669438-89ECF79B-DBA4-4AF1-AE5A-75B1714EEB41Q39862466-90F09F55-1B2D-448C-B7AE-B1F8B502AC2BQ41850841-65A51BF8-F6EC-49EF-8816-0F423E2E7041Q42258359-7D54D7D7-FCB1-4F45-8BBD-7FA8C6DDFD77Q42519592-5E80EE80-A8BB-4906-B824-7006A68BE17CQ43434366-97B00D2B-5ED4-4E48-B85E-8948B8B17026Q44647880-6D036D02-4DDD-4032-BC71-8B412FDC1948Q45071563-3F85C5AB-0791-4A9C-A206-7556D843BD83Q46152235-0FE6E61C-565B-479B-AD0E-C4442188DF10Q46395988-4959C9BF-AF5D-4DDC-BCFF-49B55ED9D471Q47267514-F9AE39BC-B8A2-468C-81EE-D0BFF2973DE0Q47665723-E2BD969D-606F-453D-AE02-A600B8FEE43BQ47886895-57A80C92-7B01-41B0-B7E8-689EBF479469
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Epidemiology of neuroendocrine tumours.
@en
Epidemiology of neuroendocrine tumours.
@nl
type
label
Epidemiology of neuroendocrine tumours.
@en
Epidemiology of neuroendocrine tumours.
@nl
prefLabel
Epidemiology of neuroendocrine tumours.
@en
Epidemiology of neuroendocrine tumours.
@nl
P2860
P356
P1433
P1476
Epidemiology of neuroendocrine tumours.
@en
P2093
P2860
P356
10.1159/000080731
P478
80 Suppl 1
P577
2004-01-01T00:00:00Z